Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A — Yohann Repessé (2019) | RDL Network
Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
Letter 2019 French
Authors
YR
Yohann Repessé
CC
Cathérine Costa
RP
Roberta Palla
Abstract
1 min read
de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
M. P. Golombek, N. H. Warner, J. A. Grant, Ernst Hauber, V. Ansan, C. M. Weitz, N. R. Williams, Constantinos Charalambous, Sharon A. Wilson, T. J. Parker, I. J. Daubar, Eloïse Marteau, Nils Mueller, S. Piqueux, W.T. Pike, A. DeMott, M. Kopp, H. Lethcoe-Wilson, L. Berger, R. B. Hausmann, M. E. Banks, Mariah Baker, James Jim Brian Garvin
A. Dubois, Pascale Bellaud, Marine Seffals, Bruno Turlin, Alain Fautrel, Gabriel Ichim, Michel Rivoire, Guillaume Passot, Zuzana Macek Jílková, Thomas Decaens, Alain Viari, Barbara Testoni, Sandra Rebouissou, Josep M. Llovet, Fabien Zoulim, Romain Parent, Charlotte A. Hernandez, Claire Verzeroli, Armando Andres Roca Suarez, Abud-José Farca-Luna, Laurie Tonon, Roger Esteban-Fabró, Roser Pinyol,
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.